Published in Eur Arch Otorhinolaryngol on January 23, 2013
Nasopharyngeal carcinoma. Lancet (2005) 7.16
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy (2004) 3.19
Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys (2005) 3.14
Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer (2004) 2.67
A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy (2006) 2.52
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol (2005) 2.30
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1995) 1.82
Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer (2004) 1.77
Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys (2005) 1.76
Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer (2010) 1.52
Nasopharyngeal carcinoma (NPC). Adv Cancer Res (1972) 1.45
Laryngoscopic detection of pharyngeal carcinoma in situ with narrowband imaging. Laryngoscope (2006) 1.44
Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett's esophagus. J Gastroenterol (2004) 1.40
Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer (1999) 1.35
Systematic review of narrow-band imaging for the detection and differentiation of neoplastic and nonneoplastic lesions in the colon (with videos). Gastrointest Endosc (2009) 1.28
Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev (2009) 1.24
Cancer susceptibility in nasopharyngeal carcinoma families--a population-based cohort study. Cancer Res (2005) 1.23
Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan. Int J Cancer (2004) 1.13
Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer (2010) 1.13
Prospective study of early detection of pharyngeal superficial carcinoma with the narrowband imaging laryngoscope. Head Neck (2009) 1.12
Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer. Am J Clin Oncol (2010) 1.12
Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol (1990) 1.09
Familial nasopharyngeal carcinoma in a cohort of 200 patients. Arch Otolaryngol Head Neck Surg (2006) 1.07
Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. Fam Cancer (2008) 1.06
Familial nasopharyngeal carcinoma. Semin Cancer Biol (2002) 1.06
Narrow-band imaging of the gastrointestinal tract. J Gastroenterol (2009) 1.05
Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. J Cancer Res Ther (2009) 1.01
Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Br J Radiol (2009) 1.00
Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening. J Clin Microbiol (2008) 1.00
Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer (2003) 0.97
Narrowband imaging for early detection of malignant tumors and radiation effect after treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg (2010) 0.96
Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer (2005) 0.94
Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan. Anticancer Res (1999) 0.91
Nasopharyngeal carcinoma detected by narrow-band imaging endoscopy. Oral Oncol (2011) 0.90
Letter: Familial aggregation in nasopharyngeal carcinoma. Lancet (1974) 0.84
Use of narrow band imaging in evaluation of possible nasopharyngeal carcinoma. Am J Rhinol Allergy (2011) 0.84
Detection of mucosal recurrent nasopharyngeal carcinomas after radiotherapy with narrow-band imaging endoscopy. Int J Radiat Oncol Biol Phys (2011) 0.81
Elevated Epstein-Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma. J Med Virol (2011) 0.78
[Application of narrow band imaging endoscopy in the diagnosis of nasopharyngeal lesions]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2011) 0.76
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? J Clin Oncol (2005) 0.75
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol (2006) 1.53
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popular. J Chin Med Assoc (2010) 1.43
Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature. Eur Arch Otorhinolaryngol (2010) 1.28
MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol (2011) 1.18
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol (2011) 1.08
Removal of unapproachable laryngopharyngeal foreign bodies under flexible videolaryngoscopy. Laryngoscope (2003) 1.01
Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol (2009) 1.00
Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci (2011) 0.99
Ectopic thyroid papillary carcinoma presenting as bilateral neck masses. J Chin Med Assoc (2010) 0.98
Salivary gland carcinoma of the larynx. J Chin Med Assoc (2006) 0.96
Predisposing factors, management, and prognostic evaluation of acute carotid blowout syndrome. J Vasc Surg (2013) 0.91
Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol (2008) 0.89
Role of chest computed tomography in head and neck cancer. Arch Otolaryngol Head Neck Surg (2008) 0.87
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck (2008) 0.86
Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma. Head Neck (2012) 0.85
Use of narrow band imaging in evaluation of possible nasopharyngeal carcinoma. Am J Rhinol Allergy (2011) 0.84
Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J Chin Med Assoc (2008) 0.84
Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells. Biomaterials (2012) 0.84
Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck (2011) 0.83
Extraparotid Warthin's tumor presented as a neck mass. J Chin Med Assoc (2003) 0.82
Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. Int J Cancer (2008) 0.82
Perineural invasion as a major determinant for the aggressiveness associated with increased tumor thickness in t1-2 oral tongue and buccal squamous cell carcinoma. Ann Surg Oncol (2013) 0.82
Sarcoma of the larynx: treatment results and literature review. J Chin Med Assoc (2006) 0.81
Laryngeal amyloidosis with airway obstruction. Otolaryngol Head Neck Surg (2002) 0.80
Perineural invasion in T1 oral squamous cell carcinoma indicates the need for aggressive elective neck dissection. Am J Surg Pathol (2013) 0.80
MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol (2011) 0.80
Predictors and timing of recovery in patients with immediate facial nerve dysfunction after parotidectomy. Head Neck (2013) 0.79
Toxic epidermal necrolysis caused by cetuximab plus minocycline in head and neck cancer. Am J Otolaryngol (2009) 0.79
Prolonged facial edema is an indicator of poor prognosis in patients with head and neck squamous cell carcinoma. Support Care Cancer (2009) 0.78
Management of base of tongue squamous cell carcinoma: experience with 85 patients in Taipei Veterans General Hospital. J Chin Med Assoc (2011) 0.78
Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy. Ann Surg Oncol (2011) 0.78
Effects of intranasal steroid spray in bacterial culture of chronic rhinosinusitis. Am J Rhinol Allergy (2009) 0.78
Partial laryngopharyngectomy in the treatment of squamous cell carcinoma of hypopharynx: analysis of the oncologic results and laryngeal preservation rate. Acta Otolaryngol (2012) 0.77
Conservation surgery for hypopharyngeal cancer: changing paradigm from open to endoscopic. Acta Otolaryngol (2013) 0.77
Communication dysfunction, body image, and symptom severity in postoperative head and neck cancer patients: factors associated with the amount of speaking after treatment. Support Care Cancer (2015) 0.77
Serum albumin is an important prognostic factor for carotid blowout syndrome. Jpn J Clin Oncol (2013) 0.77
Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma. Jpn J Clin Oncol (2011) 0.77
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma. Jpn J Clin Oncol (2011) 0.77
Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy. Head Neck (2009) 0.77
Quality of life for patients with hypopharyngeal cancer after different therapeutic modalities. Head Neck (2012) 0.76
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Cancer Chemother Pharmacol (2008) 0.76
Voice rehabilitation in laryngectomees: comparison of daily-life performance of 4 types of alaryngeal speech. J Chin Med Assoc (2003) 0.76
Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence area. J Chin Med Assoc (2011) 0.75
A combined DNA-affinic molecule and N-mustard alkylating agent has an anti-cancer effect and induces autophagy in oral cancer cells. Int J Mol Sci (2012) 0.75
Treatment selection for tonsillar squamous cell carcinoma. J Chin Med Assoc (2013) 0.75
Pathology quiz case 2. Multifocal nodular oncocytic hyperplasia (MNOH). Arch Otolaryngol Head Neck Surg (2012) 0.75
Pathology quiz case. Fibromatosis (desmoid tumor) of the neck. Arch Otolaryngol Head Neck Surg (2008) 0.75
Diagnosis and treatment of sinonasal hemangiopericytoma: Three case reports and review of the literature. J Otolaryngol (2006) 0.75
Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer. J Chin Med Assoc (2008) 0.75
Office-based treatment of vocal fold polyp with flexible laryngosvideostroboscopic surgery. J Otolaryngol Head Neck Surg (2010) 0.75
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study. Cancer Chemother Pharmacol (2010) 0.75
Sebaceous adenoma in the submandibular gland. Otolaryngol Head Neck Surg (2002) 0.75
Management of laryngeal amyloidosis--the experience of Taipei Veterans General Hospital. Zhonghua Yi Xue Za Zhi (Taipei) (2002) 0.75